Asociacion Guatemalteca del Higado (Guatemalan Liver Association)

Email

pvelez2007@gmail.com

Phone

T: 502-421-45215

Address

km 16.5 carretra al salvador, 4 ave 7-0, residencial san antonio, sta catarina pinula Guatemala
About Asociacion Guatemalteca del Higado (Guatemalan Liver Association)

The Guatemalan Liver Association, that can shorten AGH, is a private entity, non-profit, apolitical, non-religious, with medical-social character, dedicated to fight against diseases and disorders of the liver, gallbladder and biliary tract, through prevention or control activities.

It is formed by people interested in the solution of these conditions, including among its members health professionals, affected individuals and families, as well as anyone seeking the achievement of the aims of this Association.

Goals and Objectives :
1. Inform the public about the importance of the liver for life, and on the measures of prevention of diseases afflicting it.

2. Promote access to preventive measures for liver diseases.

3. To improve the quality of life of those suffering from liver diseases through:
• Inform and train health professionals on aspects of diagnosis, management and prevention of liver diseases.
• Support health services for the formulation and/or updating of guidelines for the management of liver diseases.
• Promote access to diagnosis and treatment of liver diseases.
• Inform patients and their families about the nature of these diseases.
• Encourage and support the patient´s groups and relatives to share experiences, and provide emotional support.
• Support and/or to carry out research on diseases of the liver.

Activities :

Prevention

  •  Information on general liver care and the prevention of viral hepatitis and other liver diseases. 
  • Consulting, planning, and execution of campaigns of vaccination against Hepatitis B. 

Information 

  •  Production of information materials on viral hepatitis and other liver diseases. 
  • Distribution of printed materials to patients, family members, medical and general public. 
  • Translation to the Spanish of information material, created and written in English and other languages by international organizations, these translations are being used in Spanish-speaking foreign patients. 
  • Educational talks and lectures on viral hepatitis. 

Support to patients and relatives

  • Information,advice and individual support to patients and their relatives, by telephone or in person. 
  • Lead meetings of the Support Group of patients.
  • Patient referral to providers of health services.
  • Development, processing and distribution of up-to-date information on viral hepatitis, addressed to individuals and institutions who care for patients with these diseases. 
  • Lectures, seminars and refresher courses for health personnel.

Sign up to receive updates from WHA

Name(Required)
I would like to hear about(Required)

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Hepatitis and PWID/harm reduction 

 

11:35 – 11:40  

Chair: WHO – Intro and set the scene.  

 

11:40 – 11:55  

Co-chair:  EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe. 

 

11:55 – 12:00 

ID 29: Ema Pos (not yet registered) 

Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation. 

 

12:05 – 12:10  

ID 152: Brian Conway (Registered in person) 

Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.

 

12:10 – 12:15 

ID 212: Jasmine West (not yet registered) 

Title: From lived experience to lived expertise: a syndemic approach. 

 

12:15 – 12:20 

ID: 299 Mercy Nyakowa (Registered in person) 

Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya 

 

12:20 – 12:25 

ID: 133 Nalinikanta Rajkumar (Registered in person) 

Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?  

 

12:25 – 12:30 

Q&A and closing remarks   

tHIS

 

IS 

 

BEN’S

 

 

 

BIG 

 

 

TEST

effective case finding strategies

Supported by Vir Biotechnology, Inc

During this session you will hear from hepatitis Delta expert, Dr. Maria Buti, and a patient who has lived with hepatitis Delta in a panel discussion moderated by Dr. Carey Hwang, Chief Medical Officer (interim) of Vir Biotechnology. This panel will inform perspectives on patient needs, opportunities for enhanced screening, and strengthening linkages to care.

Session Agenda

14:40 – 14:45    

Panel overview and introductions facilitated by Dr Carey Hwang (Vir Biotechnology)

14:45 – 15:05   

Panel discussion: Dr Maria Buti (University Hospital Vall d’Hebron, Spain), Milanka Barbosa, Dr Carey Hwang (Chief Medical Officer interim), Vir Biotechnology

15:05 – 15:10    

Final remarks and close